Advertisement IMDx licenses IVD products to Biosearch - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

IMDx licenses IVD products to Biosearch

Intelligent Medical Devices (IMDx) has licensed rights to Biosearch Technologies to access its molecular diagnostic testing (IVD) products BHQ, CAL Fluor and Quasar patents.

Additionally, Biosearch will develop cGMP oligonucleotides for IMDx for use in human in-vitro diagnostics.

Biosearch Technologies Corporate Development director Marc Beal said IMDx’s assays, powered by BHQ probing technologies, provides a potent combination for future diagnostic tests.

Biosearch is a supplier of oligonucleotide components to the molecular diagnostics industry, while IMDx is a developer and manufacturer of clinically impactful molecular test solutions.